Hospital Management Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Medical Care Versus Ventricular Assist Device for the Management of End-stage Heart Failure (MEVADE)
Conditions: Heart Failure; Heart Transplantation; Heart-Assist Devices Intervention: Sponsor: Groupe Hospitalier Pitie-Salpetriere Completed - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2017 Category: Research Source Type: clinical trials
Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.
Conditions: Glioblastoma; Molecular Disease Intervention: Other: Correlation between molecular anomalies of the primary tumor and circulating tumor DNA Sponsor: Centre Hospitalier Universitaire, Amiens Recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2017 Category: Research Source Type: clinical trials
Medical Care Versus Ventricular Assist Device for the Management of End-stage Heart Failure (MEVADE)
Conditions: Heart Failure; Heart Transplantation; Heart-Assist Devices Intervention: Sponsor: Groupe Hospitalier Pitie-Salpetriere Completed - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2017 Category: Research Source Type: clinical trials
Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.
Conditions: Glioblastoma; Molecular Disease Intervention: Other: Correlation between molecular anomalies of the primary tumor and circulating tumor DNA Sponsor: Centre Hospitalier Universitaire, Amiens Recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2017 Category: Research Source Type: clinical trials
Medical Care Versus Ventricular Assist Device for the Management of End-stage Heart Failure (MEVADE)
Conditions: Heart Failure; Heart Transplantation; Heart-Assist Devices Intervention: Sponsor: Groupe Hospitalier Pitie-Salpetriere Completed - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2017 Category: Research Source Type: clinical trials
Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.
Conditions: Glioblastoma; Molecular Disease Intervention: Other: Correlation between molecular anomalies of the primary tumor and circulating tumor DNA Sponsor: Centre Hospitalier Universitaire, Amiens Recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2017 Category: Research Source Type: clinical trials
Medical Care Versus Ventricular Assist Device for the Management of End-stage Heart Failure (MEVADE)
Conditions: Heart Failure; Heart Transplantation; Heart-Assist Devices Intervention: Sponsor: Groupe Hospitalier Pitie-Salpetriere Completed - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2017 Category: Research Source Type: clinical trials
Small Doses of Pituitrin Versus Norepinephrine for the Management of Vasoplegic Syndrome in Patients After Cardiac Surgery
Condition: Postoperative Vasoplegic Syndrome Interventions: Drug: Pituitrin infusion; Drug: Norepinephrine infusion Sponsor: Beijing Anzhen Hospital Recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2017 Category: Research Source Type: clinical trials
